Table 1 Baseline clinical characteristics of the patients.

From: Cardiovascular morbidities in postoperative colorectal cancer patients

 

Study population (N = 2875)

Patients with new-onset CVD (n = 141)

Patients without new-onset CVD (n = 2734)

p

Age, median (IQR)

62.0 (IQR, 54.0–70.0)

70.0 (IQR, 61.0–75.0)

61.0 (IQR, 53.0–70.0)

< 0.001

Age > 65 years, n (%)

1138 (39.6)

90 (63.8)

1048 (38.3)

< 0.001

Sex, male (%)

1727 (60.1)

104 (73.8)

1623 (59.4%)

0.001

BMI, median (IQR)

23.5 (IQR, 21.5–25.55)

24.0 (IQR, 21.85–25.8)

23.5 (21.5–25.5)

0.572

Hypertension, n (%)

1094 (38.1)

85 (60.3)

1009 (36.9)

< 0.001

Diabetes mellitus, n (%)

512 (17.8)

59 (41.8)

453 (16.6)

 < 0.001

Hyperlipidemia, n (%)

269 (9.4)

11 (7.8)

258 (9.4)

0.656

Coronary arterial disease, n (%)

120 (4.2)

49 (34.8)

71 (2.6)

< 0.001

Pulmonary disease, n (%)

141 (4.9)

8 (5.7)

133 (4.9)

0.687

Ischemic stroke, n (%)

61 (2.1)

11 (7.8)

50 (1.8)

< 0.001

Valvular heart disease, n (%)

701 (24.4)

39 (27.6)

662 (24.2)

0.366

Atrial fibrillation, n (%)

31 (1.1)

5 (3.5)

26 (1.0)

0.016

Chronic kidney disease, n (%)

59 (2.1)

12 (8.5)

47 (1.7)

< 0.001

ASA, n (%)

1

934 (32.5)

10 (7.1)

924 (33.8)

< 0.001

2

1794 (62.4)

76 (53.9)

1718 (62.8)

3

126 (4.4)

46 (32.6)

80 (2.9)

4

21 (0.7)

9 (6.4)

12 (0.4)

ECOG, n (%)

1

2659 (92.5)

102 (72.3)

2557 (93.5)

< 0.001

2

206 (7.2)

34 (24.1)

172 (6.3)

3

8 (0.3)

3 (2.1)

5 (0.2)

4

2 (0.1)

2 (14)

0

Smoking, n (%)

Current smoker

247 (8.6)

19 (13.5)

228 (8.3)

0.003

Ex-smoker

1006 (35.0)

56 (39.7)

950 (34.7)

Alcohol, n (%)

Current drinker

515 (17.9)

33 (23.6)

482 (17.6)

0.247

Ex-drinker

936 (32.6)

40 (28.6)

896 (32.8)

Total cholesterol, mean (SD)

153.09 (35.0)

141.3 (37.7)

153.7 (34.8)

< 0.001

CRP, mean (SD)

0.48 (1.64)

0.68 (1.79)

0.46 (1.60)

0.190

  1. CVD cardiovascular disease, IQR interquartile range, BMI body mass index, ASA American Society of Anesthesiologists Physical Status Classification System, ECOG Eastern Cooperative Oncology Group performance status, SD standard deviation, CRP c-reactive protein.